OPLEZEVE
LIVE

Serial Number

99284520

Owner

Merck Sharp & Dohme B.V.

Attorney

Lisa M. Dellamura

Filing Date

Jul 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OPLEZEVE Trademark

Serial Number: 99284520 • Registration: 8137192

OPLEZEVE is a trademark filed by Merck Sharp & Dohme B.V. on July 15, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Merck Sharp & Dohme B.V. (40 trademarks)

Waarderweg 39
HAARLEM 2031BN , NL

Entity Type: 26

Trademark Details

Filing Date

July 15, 2025

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 26, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 26, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 20, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 20, 2025 GNSL
SUSPENSION LETTER WRITTEN
Sep 20, 2025 CNSL
ASSIGNED TO EXAMINER
Sep 19, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2025 NWOS
NEW APPLICATION ENTERED
Jul 15, 2025 NWAP